Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-01-03 @ 6:27 AM
Study NCT ID:
NCT04635735
Status:
TERMINATED
Last Update Posted:
2023-03-23
First Post:
2020-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-13
First Submit QC Date:
None
Study First Post Date:
2020-11-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-03
Results First Submit QC Date:
None
Results First Post Date:
2023-03-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-22
Last Update Post Date:
2023-03-23
Last Update Post Date Type:
ACTUAL